Twist Bioscience Corp. (NASDAQ:TWST) Q3 2021 Earnings Conference Call August 6, 2021 8:00 AM ET
Company Participants
Emily Leproust – CEO and Co-Founder
Angela Bitting – SVP of Corporate Affairs
Jim Thorburn – CFO
Conference Call Participants
Doug Schenkel – Cowen
Matt Sykes – Goldman Sachs
Catherine Schulte – Baird
Vijay Kumar – Evercore ISI
Matt Larew – William Blair (ph)
Tycho Peterson – JP Morgan
Operator
Welcome to Twist Biosciences, Fiscal 2021, Third Quarter Financial results conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a Q&A session.
[Operators instructions] As reminder, today's conference call is being recorded. I would now like to turn the conference over to Angela Bitting SVP of Corporate Affairs.
Angela Bitting
Thank you, Valerie. Good morning everyone. I would like to thank all of you for joining us today for Twist Biosciences Conference call to review our Fiscal 2021 Third Quarter financial results and business progress.
We did issue our financial results released this morning, which is available at our website at www.twistbioscience.com. With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist, and Jim Thorburn, CFO of Twist.
Emily will begin with a review of our recent progress on Twist Businesses. Jim will report on our financial and operational performance, and Emily will come back to discuss our upcoming milestones and direction.
We'll then open the call for questions. As a reminder, this call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for two weeks. During today's presentation, we will be making forward-looking statements within the meaning of the U.S federal securities laws.
Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and
- Read more current TWST analysis and news
- View all earnings call transcripts